Steven W. King
2013
In 2013, Steven W. King earned a total compensation of $1.1M as President and Chief Executive Officer at Peregrine Pharmaceuticals, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $313,706 |
|---|---|
| Option Awards | $349,410 |
| Salary | $445,830 |
| Other | $35,699 |
| Total | $1,144,645 |
King received $445.8K in salary, accounting for 39% of the total pay in 2013.
King also received $313.7K in non-equity incentive plan, $349.4K in option awards and $35.7K in other compensation.
Rankings
In 2013, Steven W. King's compensation ranked 6,025th out of 12,286 executives tracked by ExecPay. In other words, King earned more than 51.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,025 out of 12,286 | 51st |
Division Manufacturing | 2,092 out of 4,612 | 55th |
Major group Chemicals And Allied Products | 613 out of 1,462 | 58th |
Industry group Drugs | 441 out of 1,156 | 62nd |
Industry Pharmaceutical Preparations | 355 out of 890 | 60th |
Source: SEC filing on August 28, 2014.
King's colleagues
We found five more compensation records of executives who worked with Steven W. King at Peregrine Pharmaceuticals in 2013.
2013
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
2013
Jeffrey Masten
Peregrine Pharmaceuticals
Former Vice President, Quality
2013
Mark Ziebell
Peregrine Pharmaceuticals
General Counsel
2013
Shelley Fussey
Peregrine Pharmaceuticals
Vice President, Intellectual Property
2013
Joseph Shan
Peregrine Pharmaceuticals